Houston, TEXAS4 Active Studies

ADHD Clinical Trials in Houston, TEXAS

Find 4 actively recruiting adhd clinical trials in Houston, TEXAS. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
381
Enrolling

Recruiting ADHD Studies in Houston

RecruitingHouston, TEXASNCT06305767

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

Researchers are looking for new ways to treat people with high-risk muscle-invasive urothelial carcinoma (MIUC). Urothelial carcinoma is a type of bladder cancer that begins in cells that line the ins...

230 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingHouston, TEXASNCT05710848

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients wit...

75 participants
SURGE Therapeutics
View Study Details
RecruitingHouston, TEXASNCT05137262

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

This is a phase II randomized study of standard of care (SOC) neo-adjuvant cisplatin chemotherapy (NAC) versus NAC plus durvalumab in patients with either clinical or pathologic intra-pelvic node-posi...

60 participants
M.D. Anderson Cancer Center
View Study Details
RecruitingHouston, TEXASNCT06596291

Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

This is a first-in-human, Phase 1b/2a, open-label, dose-escalation study of a single treatment course consisting of multiple intradetrusor injections of EG110A in male and female adult participants wi...

16 participants
EG 427
View Study Details

About ADHD Clinical Trials in Houston

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 4 adhd clinical trials recruiting participants in Houston, TEXAS. These studies are seeking a combined 381 participants. Research is being sponsored by Merck Sharp & Dohme LLC, SURGE Therapeutics, M.D. Anderson Cancer Center and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Houston — FAQ

Are there adhd clinical trials in Houston?

Yes, there are 4 adhd clinical trials currently recruiting in Houston, TEXAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Houston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Houston research site will contact you about next steps.

Are clinical trials in Houston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Houston studies also compensate for your time and travel.

What adhd treatments are being tested?

The 4 active trials in Houston are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated March 2, 2026 from ClinicalTrials.gov